These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15551348

  • 1. Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
    Kivi A, Trottenberg T, Kupsch A, Plotkin M, Felix R, Niehaus L.
    Mov Disord; 2005 Feb; 20(2):258-60. PubMed ID: 15551348
    [No Abstract] [Full Text] [Related]

  • 2. [Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
    Pérez Errazquin F, Gomez Heredia MJ.
    Neurologia; 2012 Apr; 27(3):181-3. PubMed ID: 21570743
    [No Abstract] [Full Text] [Related]

  • 3. Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans.
    Lang AE, Garnett ES.
    Ann Neurol; 1990 Oct; 28(4):592-3. PubMed ID: 2252376
    [No Abstract] [Full Text] [Related]

  • 4. Parkinsonism due to ephedrone neurotoxicity: a case report.
    Colosimo C, Guidi M.
    Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409
    [No Abstract] [Full Text] [Related]

  • 5. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW.
    Mov Disord; 2009 Dec 15; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract] [Full Text] [Related]

  • 6. Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
    Pita Lobo P, Coelho M, Mestre TA, Rosa MM, Ferreira JJ.
    Mov Disord; 2013 Aug 15; 28(9):1212-4. PubMed ID: 23861327
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism.
    Tinazzi M, Antonini A, Bovi T, Pasquin I, Steinmayr M, Moretto G, Fiaschi A, Ottaviani S.
    J Neurol; 2009 Jun 15; 256(6):910-5. PubMed ID: 19252795
    [Abstract] [Full Text] [Related]

  • 8. Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Lang AE.
    Mov Disord; 1995 Jul 15; 10(4):489-95. PubMed ID: 7565831
    [Abstract] [Full Text] [Related]

  • 9. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
    Ohta K, Obara K.
    Mov Disord; 2006 Jan 15; 21(1):124-5. PubMed ID: 16229001
    [No Abstract] [Full Text] [Related]

  • 10. Hemiparkinsonism and levodopa-induced dyskinesias following focal nigral lesion.
    Alves R, Barbosa E, Scaff M.
    Mov Disord; 2006 Dec 15; 21(12):2267-8; author reply 2268. PubMed ID: 17078068
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.
    Healy DG, Bressman S, Dickson J, Silveira-Moriyama L, Schneider SA, Sullivan SS, Massey L, Bhatia KP, Shaw K, Bhatia KP, Bomanji J, Wood NW, Lees AJ.
    Mov Disord; 2009 Jun 15; 24(8):1245-7. PubMed ID: 19260103
    [No Abstract] [Full Text] [Related]

  • 12. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.
    Růzicka E, Urgosík D, Jech R, Roth J, Vymazal J, Mecír P, Vladyka V.
    Mov Disord; 2005 Jun 15; 20(6):759-62. PubMed ID: 15782419
    [Abstract] [Full Text] [Related]

  • 13. Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.
    Orta Daniel SJ, Ulises RO.
    Parkinsonism Relat Disord; 2008 Jun 15; 14(4):367-9. PubMed ID: 18455950
    [Abstract] [Full Text] [Related]

  • 14. Parkinsonism after glycine-derivate exposure.
    Barbosa ER, Leiros da Costa MD, Bacheschi LA, Scaff M, Leite CC.
    Mov Disord; 2001 May 15; 16(3):565-8. PubMed ID: 11391760
    [Abstract] [Full Text] [Related]

  • 15. Dopa-responsive parkinsonism secondary to right temporal lobe haemorrahage.
    Ling MJ, Aggarwal A, Morris JG.
    Mov Disord; 2002 Mar 15; 17(2):402-4. PubMed ID: 11921132
    [Abstract] [Full Text] [Related]

  • 16. The L-dopa response in vascular parkinsonism.
    Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ.
    J Neurol Neurosurg Psychiatry; 2004 Apr 15; 75(4):545-7. PubMed ID: 15026493
    [Abstract] [Full Text] [Related]

  • 17. Levodopa responsive hemidystonia associated with contralateral nigral lesion.
    Lyoo CH, Lee MS.
    J Neurol; 2010 May 15; 257(5):856-7. PubMed ID: 20127249
    [No Abstract] [Full Text] [Related]

  • 18. Parkinsonism associated with acute intracranial hematomas: an [18F]dopa positron-emission tomography study.
    Turjanski N, Pentland B, Lees AJ, Brooks DJ.
    Mov Disord; 1997 Nov 15; 12(6):1035-8. PubMed ID: 9399232
    [Abstract] [Full Text] [Related]

  • 19. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
    Zijlmans J, Evans A, Fontes F, Katzenschlager R, Gacinovic S, Lees AJ, Costa D.
    Mov Disord; 2007 Jul 15; 22(9):1278-85. PubMed ID: 17486613
    [Abstract] [Full Text] [Related]

  • 20. Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.
    Lee PH, Joo US, Bang OY, Seo CH.
    Neurology; 2004 Jul 27; 63(2):395-6. PubMed ID: 15277652
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.